These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR. Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387 [Abstract] [Full Text] [Related]
9. Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Chaturvedi RK, Agrawal AK, Seth K, Shukla S, Chauhan S, Shukla Y, Sinha C, Seth PK. Int J Dev Neurosci; 2003 Nov 18; 21(7):391-400. PubMed ID: 14599485 [Abstract] [Full Text] [Related]
10. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo. Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK. Neuroscience; 2008 Jun 23; 154(2):606-20. PubMed ID: 18472226 [Abstract] [Full Text] [Related]
11. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease. Quinn M, Mukhida K, Sadi D, Hong M, Mendez I. Eur J Neurosci; 2008 Jan 23; 27(1):43-52. PubMed ID: 18093176 [Abstract] [Full Text] [Related]
16. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S. Neurochem Int; 2008 Jun 23; 52(7):1332-42. PubMed ID: 18372079 [Abstract] [Full Text] [Related]
17. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease. Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J. Exp Neurol; 2001 Jan 23; 167(1):148-57. PubMed ID: 11161602 [Abstract] [Full Text] [Related]
18. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Di Loreto S, Florio T, Capozzo A, Napolitano A, Adorno D, Scarnati E. Exp Neurol; 1996 Apr 23; 138(2):318-26. PubMed ID: 8620930 [Abstract] [Full Text] [Related]
19. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC. Cell Transplant; 2009 Apr 23; 18(7):801-14. PubMed ID: 19796495 [Abstract] [Full Text] [Related]
20. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. Wictorin K, Brundin P, Sauer H, Lindvall O, Björklund A. J Comp Neurol; 1992 Sep 22; 323(4):475-94. PubMed ID: 1358925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]